Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Epidemiology of Kawasaki disease in infants 3 months of age and younger

  • Lee, Eun Jung (Department of Pediatrics, The Catholic University of Korea School of Medicine) ;
  • Park, Yong Won (Department of Pediatrics, Inje University College of Medicine) ;
  • Hong, Young Mi (Department of Pediatrics, Ewha Womans University School of Medicine) ;
  • Lee, Joon Sung (Department of Pediatrics, The Catholic University of Korea School of Medicine) ;
  • Han, Ji Whan (Department of Pediatrics, The Catholic University of Korea School of Medicine)
  • Received : 2011.09.15
  • Accepted : 2011.12.27
  • Published : 2012.06.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study investigated the epidemiology of Kawasaki disease (KD) in infants ${\leq}3$-month-old. Methods: To study the epidemiology of KD in Korea, data for 27,851 KD patients were collected on a 3-year basis between 2000 and 2008 in a retrospective survey. From this, data for 609 KD patients ${\leq}3$-month-old were analyzed and compared with the data for KD patients >3-month-old. Results: The 609 KD patients ${\leq}3$-month-old (385 males and 224 females) constituted 2.2% of the KD patients. They included 25 infants <1-month-old, 198 infants ${\leq}1$- to 2-month-old, and 386 infants >2- and 3-months-old. The ratio of males to females was 1.72:1. The incidence of coronary artery (CA) dilatation (19.9% vs. 18.7%) and CA aneurysms (3.4% vs. 2.6%) detected by echocardiography did not differ significantly between patients with KD younger and older than 3-month-old. Conclusion: Compared with the data for the KD patients >3-month-old, the data for the 609 patients ${\leq}3$-month-old did not show a significantly higher incidence of CA dilatation or CA aneurysms.

Keywords

References

  1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178-222.
  2. Melish ME. Kawasaki syndrome. Pediatr Rev 1996;17:153-62. https://doi.org/10.1542/pir.17-5-153
  3. Rowley AH, Shulman ST. Kawasaki syndrome. Pediatr Clin North Am 1999;46:313-29. https://doi.org/10.1016/S0031-3955(05)70120-6
  4. Burns JC, Wiggins JW Jr, Toews WH, Newburger JW, Leung DY, Wilson H, et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 1986;109:759-63. https://doi.org/10.1016/S0022-3476(86)80689-8
  5. Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J 2006;25:241-4. https://doi.org/10.1097/01.inf.0000202067.50975.90
  6. Yun YS, Kim CH, Kim CH, Tockgo YC, Lee SK, Hong CY. Kawasaki disease in Korea. In: Kato H, editor. Kawasaki disease. New York: Elsevier, 1995:30-3.
  7. Park YW, Kim CH, Park IS, Ma JS, Lee SB, Kim CH, et al. Epidemiologic study of Kawasaki disease in Korea, 1994-1996: comparison of previous study in 1991-1993. J Korean Pediatr Soc 1999;42:1255-60.
  8. Park YW, Park IS, Kim CH, Ma JS, Lee SB, Kim CH, et al. Epidemiologic study of Kawasaki disease in Korea, 1997-1999: comparison with previous studies during 1991-1996. J Korean Med Sci 2002;17:453-6.
  9. Park YW, Han JW, Park IS, Kim CH, Yun YS, Cha SH, et al. Epidemiologic picture of Kawasaki disease in Korea, 2000-2002. Pediatr Int 2005;47:382-7. https://doi.org/10.1111/j.1442-200x.2005.02079.x
  10. Park YW, Han JW, Park IS, Kim CH, Cha SH, Ma JS, et al. Kawasaki disease in Korea, 2003-2005. Pediatr Infect Dis J 2007;26:821-3. https://doi.org/10.1097/INF.0b013e318124aa1a
  11. Park YW, Han JW, Hong YM, Ma JS, Cha SH, Kwon TC, et al. Epidemiological features of Kawasaki disease in Korea, 2006-2008. Pediatr Int 2011;53:36-9. https://doi.org/10.1111/j.1442-200X.2010.03178.x
  12. Research Committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo: Ministry of Health, Labour and Welfare, 1984.
  13. Tsuchida S, Yamanaka T, Tsuchida R, Nakamura Y, Yashiro M, Yanagawa H. Epidemiology of infant Kawasaki disease with a report of the youngest neonatal case ever reported in Japan. Acta Paediatr 1996;85: 995-7. https://doi.org/10.1111/j.1651-2227.1996.tb14201.x
  14. Iino M, Shiraishi H, Igarashi H, Honma Y, Momoi MY. Case of Kawasaki disease in NICU. Pediatr Int 2003;45:580-3. https://doi.org/10.1046/j.1442-200X.2003.01766.x
  15. Chuang CH, Hsiao MH, Chiu CH, Huang YC, Lin TY. Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect 2006;39:387-91.
  16. Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr 2000;137:250-2. https://doi.org/10.1067/mpd.2000.105150
  17. Park YW, Han JW, Park IS, Kim CH, Cha SH, Ma JS, et al. Clinical and epidemiologic study of Kawasaki disease in children 8 years of age and older. Korean J Pediatr 2005;48:1139-42.
  18. Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr 1995;126:524-9. https://doi.org/10.1016/S0022-3476(95)70344-6
  19. Yanagawa H, Nakamura Y, Yashiro M, Ojima T, Tanihara S, Oki I, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics 1998;102:E65. https://doi.org/10.1542/peds.102.6.e65
  20. Park YW, Han JW, Park IS, Kim CH, Cha SH, Ma JS, et al. Epidemiologic study of Kawasaki disease in 6 months old and younger infants. Korean J Pediatr 2008;51:1320-3. https://doi.org/10.3345/kjp.2008.51.12.1320

Cited by

  1. Concurrent Adrenal Neuroblastoma and Kawasaki Disease: A Report of a Rare Case vol.2013, pp.None, 2013, https://doi.org/10.1155/2013/931703
  2. Kawasaki disease in infants vol.56, pp.9, 2013, https://doi.org/10.3345/kjp.2013.56.9.377
  3. Epidemiologic Features and Prognostic Factors of Coronary Artery Lesions Associated With Kawasaki Disease Based on a 13-Year Cohort of Consecutive Cases Identified by Complete Enumeration Surveys in W vol.24, pp.5, 2012, https://doi.org/10.2188/jea.je20140018
  4. Clinical characteristics and serum N-terminal pro-brain natriuretic peptide as a diagnostic marker of Kawasaki disease in infants younger than 3 months of age vol.57, pp.8, 2014, https://doi.org/10.3345/kjp.2014.57.8.357
  5. Neonatal Kawasaki disease: case report and data from nationwide survey in Japan vol.173, pp.11, 2012, https://doi.org/10.1007/s00431-014-2347-x
  6. Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki di vol.5, pp.12, 2015, https://doi.org/10.1136/bmjopen-2015-009562
  7. Clinical Characteristics of Kawasaki Disease in Infants Younger than Six Months: A Single-Center Study vol.46, pp.4, 2016, https://doi.org/10.4070/kcj.2016.46.4.550
  8. A 3-month-old infant with atypical Kawasaki disease vol.2018, pp.may_129, 2012, https://doi.org/10.1136/bcr-2017-221456
  9. Kawasaki disease in infants 3 months of age and younger: a multicentre Spanish study vol.78, pp.2, 2012, https://doi.org/10.1136/annrheumdis-2018-213891
  10. Clinical features and mid‐term follow‐up in infants younger than 3 months with Kawasaki disease in a Chinese population vol.55, pp.5, 2019, https://doi.org/10.1111/jpc.14233
  11. Kawasaki disease in infants less than one year of age: an Italian cohort from a single center vol.19, pp.1, 2019, https://doi.org/10.1186/s12887-019-1695-0
  12. Kawasaki Disease in Infants in the First 3 Months of Age in a Mexican Population: A Cautionary Tale vol.8, pp.None, 2020, https://doi.org/10.3389/fped.2020.00397
  13. Association between the miRNA‐149 rs2292832 T>C polymorphism and Kawasaki disease susceptibility in a southern Chinese population vol.34, pp.4, 2012, https://doi.org/10.1002/jcla.23125
  14. Neonatal Kawasaki disease with multiple arterial aneurysms: a case report vol.18, pp.1, 2012, https://doi.org/10.1186/s12969-020-00440-x
  15. Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized vol.22, pp.1, 2021, https://doi.org/10.1186/s13063-021-05807-3